Central Provident Fund Act
(Chapter 36, Section 57)
Central Provident Fund (Medishield Scheme) Regulations
Rg 20
G.N. No. S 427/2005

REVISED EDITION 2008
(2nd June 2008)
[1st July 2005]
PART I
PRELIMINARY
Citation
1.  These Regulations may be cited as the Central Provident Fund (MediShield Scheme) Regulations.
Definitions
2.  In these Regulations, unless the context otherwise requires —
“approved community hospital” means any premises which, in the opinion of the Minister for Health, provides an intermediate level of care for out-patients and in-patients who have simple ailments that do not require specialist medical and nursing care and which is approved by that Minister for the purposes of these Regulations;
“approved hospital” means any hospital, clinic or centre which provides medical treatment and which is approved by the Minister for Health for the purposes of these Regulations;
“approved medical practitioner” means any medical practitioner who is approved by the Minister for Health or such other person as he may appoint for the purposes of these Regulations;
“approved private hospital” means any private hospital approved by the Minister for Health for the purposes of these Regulations;
“approved restructured hospital” means any restructured hospital approved by the Minister for Health for the purposes of these Regulations;
“assured amount”  —
(a)in relation to each item of medical treatment received by a person insured under the Scheme in Division 2 of Part II, means the amount specified in the second column of the Third Schedule in respect of that item of medical treatment;
(b)in relation to each item of medical treatment received before 1st October 2005 by a person insured under Plan A of the Scheme in Division 3 of Part II, means the amount specified in the third column of the Third Schedule in respect of that item of medical treatment;
(c)in relation to each item of medical treatment received before 1st October 2005 by a person insured under Plan B of the Scheme in Division 3 of Part II, means the amount specified in the fourth column of the Third Schedule in respect of that item of medical treatment;
“claim limit”, in relation to each item of medical treatment, means the charge levied by the approved hospital for that item of medical treatment or the assured amount for that item of medical treatment, whichever is the lower;
“day surgical treatment” means any surgical treatment (including any radiosurgery treatment) received by a person who is admitted and discharged on the same day, and includes any ancillary medical treatment received by that person between such admission and discharge, but shall not include any treatment, service or item specified in the First Schedule;
[S 726/2011 wef 30/12/2011]
“dependant”, in relation to a member, means —
(a)a member’s spouse, child, parent or grandparent; or
(b)any other person who is dependent on the member and whom the Board may approve for the purpose of these Regulations;
[Deleted by S 726/2011 wef 30/12/2011]
“gamma knife treatment” means the treatment of neurosurgical and neurological disorders by way of radiotherapeutic procedure as specified in the Central Provident Fund (Medisave Account Withdrawals) Regulations (Rg 17) in force immediately before 1st May 2007;
“Government premium rebate” means the sum of money, equivalent to the amount of premium payable under the Scheme in Division 2 of Part II after deducting any premium rebate in regulation 17, which may be paid by the Government to a person under the MediShield Scheme for the Elderly;
“incapacitated” has the same meaning as in section 28 of the Act;
“insured’s contribution”, in relation to any claim by an insured person, means the amount specified in the Fourth Schedule for which the insured person is responsible under the Scheme in respect of any one or more claims in a policy year;
“insured out-patient medical treatment” means any of the following medical treatment as an out-patient of any approved hospital:
(a)renal dialysis;
(b)treatment of neoplasms by chemotherapy;
(c)radiotherapy treatment for cancer;
(d)administration of immunosuppressants for organ transplant;
(e)administration of erythropoietin for dialysis and chronic renal failure;
“insurer” means any insurer which is registered under the Insurance Act (Cap. 142);
“integrated medical insurance plan” means any plan under which a person is insured —
(a)under a medical insurance policy which is approved by the Minister for Health for the purposes of regulation 4(1)(b) of the Central Provident Fund (Private Medical Insurance Scheme) Regulations (Rg 26); and
(b)where applicable, under the Scheme in Division 2 of Part II;
“lifetime claim limit” means the total amount that may be claimed by an insured person under the Scheme in his lifetime;
“living donor organ transplant” has the same meaning as in the Human Organ Transplant Act (Cap. 131A);
[S 89/2010 wef 17/02/2010]
“medical practitioner” means any medical practitioner registered under the Medical Registration Act (Cap. 174) or any dentist registered under the Dental Registration Act (Cap. 76);
“medical treatment”  —
(a)includes —
(i)any surgical treatment, radiotherapy treatment, treatment of neoplasms by chemotherapy, renal dialysis treatment or radiosurgery treatment;
(ii)any service, investigation, medicine, curative material, medical consumable, surgical implant or other item necessary for the medical treatment; and
(iii)where any medical treatment has been received by a person as an in-patient in an approved hospital, the maintenance of that person in the hospital; but
(b)shall not include any treatment, service or item specified in the First Schedule;
[S 726/2011 wef 30/12/2011]
“member” includes a member who is an undischarged bankrupt;
“national school” means —
(a)a school which is organised and conducted directly by the Government;
(b)a school which is in receipt of grant-in-aid under the Education (Grant-in-Aid) Regulations (Cap. 87, Rg 3); or
(c)a school which is named in any order made under section 3(1) of the School Boards (Incorporation) Act (Cap. 284A);
“organ transplantation costs” means —
(a)any costs arising in relation or incidental to the removal of any organ from a non-living organ donor for organ transplant and includes the costs of —
(i)the donor’s extended stay, before his death, in a hospital as necessitated by the donation of his organ;
(ii)any surgical operation to remove the organ from the donor’s body;
(iii)any pre-harvesting laboratory test and investigation;
(iv)any counselling provided to the donor’s family in connection with the donation of his organ;
(v)the storage and transport of the organ; and
(vi)such other procedure as may be approved by the Minister for Health; or
(b)any costs so far as are reasonably or directly attributable to the removal of any specified organ from a living organ donor for organ transplant and includes the costs of —
(i)the donor’s stay in a hospital as necessitated by the donation of his specified organ until he is discharged;
(ii)any surgical operation to remove the specified organ from the donor’s body;
(iii)the storage and transport of the specified organ; and
(iv)such other procedure as may be approved by the Minister for Health,
but does not include —
(A)any costs arising in relation or incidental to complications suffered by the donor due to the donation of his specified organ after his discharge from the hospital under sub-paragraph (i);
(B)any pre-harvesting laboratory test and investigation; and
(C)any counselling provided to the donor’s family in connection with the donation of his specified organ;
[S 89/2010 wef 17/02/2010]
“Plan” means Plan A or Plan B, as the case may be, of the Scheme in Division 3 of Part II;
“policy year” means a period of 12 months from the date of the commencement or renewal of an insured person’s insurance cover under the Scheme;
“policy year limit” means the total amount that may be claimed by an insured person under the Scheme in a policy year;
“premium” means the premium payable by an insured person or by a member whose dependant is an insured person in each policy year under the Scheme;
“premium rebate” means the premium rebate specified in regulation 17;
“private medical insurance plan” means any medical insurance policy which is approved by the Minister for Health for the purposes of regulation 4(1)(a) of the Central Provident Fund (Private Medical Insurance Scheme) Regulations (Rg 26);
“radiosurgery treatment” has the same meaning as in the Central Provident Fund (Medisave Account Withdrawals) Regulations (Rg 17) and shall not include any treatment, service or item specified in the First Schedule;
[S 726/2011 wef 30/12/2011]
“Scheme” means the MediShield Scheme in Division 2 or 3, as the case may be, of Part II;
“specified organ” has the same meaning as in the Human Organ Transplant Act (Cap. 131A);
[S 89/2010 wef 17/02/2010]
“treatment of neoplasms by chemotherapy” means the administration of tested and approved chemotherapeutic agents by the usual and known routes in the treatment of malignant neoplasms, certain benign neoplasms and neoplasms of uncertain behaviour as approved by the Minister for Health for the purposes of these Regulations;
Persons who are not entitled to join Scheme
3.—(1)  Except as expressly provided otherwise in these Regulations, a person shall not be entitled to join the Scheme, if —
(a)he has attained the age of 85 years;
(b)he is neither a citizen nor a permanent resident of Singapore;
(c)the Board is satisfied that he is incapacitated;
(d)the Board is satisfied that he lacks capacity within the meaning of section 4 of the Mental Capacity Act (Cap. 177A);
[S 726/2011 wef 30/12/2011]
(e)the Board is satisfied that he is suffering from a terminal illness or disease; or
[S 726/2011 wef 30/12/2011]
(f)the Board is not satisfied that he is in good health.
[S 726/2011 wef 30/12/2011]
(2)  Notwithstanding paragraph (1), the Board may permit a person to whom paragraph (1)(c), (d) or (f) applies to join the Scheme subject to such terms and conditions as the Board may impose.
[S 653/2010 wef 01/11/2010]
[S 726/2011 wef 30/12/2011]